Kar, M. Et Al. 2022. Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26 , 65-71.

Kar, M., Ince, I., Yildirim, C., BURUKOĞLU DÖNMEZ, D., Karasulu, Y., & CİNGİ, C., (2022). Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, 65-71.

Kar, M. Et Al. "Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, 65-71, 2022

Kar, M. Et Al. "Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, pp.65-71, 2022

Kar, M. Et Al. (2022) . "Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, pp.65-71.

@article{article, author={M. Kar Et Al. }, title={Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment}, journal={EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES}, year=2022, pages={65-71} }